Copyright West LLC. Minimum 15 minutes delayed.

Investors & Media

Biography

J. Kevin Buchi

Chairman

Kevin Buchi, the former president and chief executive officer of Cephalon, Inc. and TetraLogic Pharmaceuticals, joined the Dicerna board of directors in August 2018, and was appointed chairman of the board in January 2019. He previously served as corporate vice president of global branded products at Teva Pharmaceutical Industries Limited from 2011 to May 2012, after Teva acquired Cephalon in October 2011.

 

Mr. Buchi joined Cephalon in 1991 and, during his tenure, held various leadership positions, including chief financial officer and chief operating officer, before becoming Cephalon’s chief executive officer in December 2010. In addition, Mr. Buchi currently serves as a director of Amneal Pharmaceuticals, Inc. and Benitec Biopharma Ltd. Mr. Buchi has previously served on the boards of several pharmaceutical companies, including EPIRUS Biopharmaceuticals, Inc., Alexza Pharmaceuticals, Inc. and Forward Pharma A/S.

<<Back